Serum selenium and serum lipids in US adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004

Abstract

ObjectiveHigh selenium has been recently associated with several cardiovascular and metabolic risk factors including diabetes, blood pressure and lipid levels. We evaluated the association of serum selenium with fasting serum lipid levels in the National Health and Nutrition Examination Survey (NHANES) 2003–2004, the most recently available representative sample of the US population that measured selenium levels. MethodsCross-sectional analysis of 1159 adults ≥40 years old from NHANES 2003–2004. Serum selenium was measured by inductively coupled plasma-dynamic reaction cell-mass spectrometry. Fasting serum total cholesterol, triglycerides, and HDL cholesterol were measured enzymatically and LDL cholesterol was calculated. ResultsMean serum selenium was 136.7μg/L. The multivariable adjusted average differences (95% confidence interval) comparing the highest (≥147μg/L) to the lowest (<124μg/L) selenium quartiles were 18.9 (9.9, 28.0)mg/dL for total cholesterol, 12.7 (3.3, 22.2)mg/dL for LDL cholesterol, 3.9 (0.4, 7.5)mg/dL for HDL cholesterol, and 11.5 (−7.6, 30.7)mg/dL for triglycerides. In spline regression models, total and LDL cholesterol levels increased progressively with increasing selenium concentrations. HDL cholesterol increased with selenium but reached a plateau above 120μg/L of serum selenium (20th percentile). The triglyceride–selenium relationship was U-shaped. ConclusionIn US adults, high serum selenium concentrations were associated with increased serum concentrations of total and LDL cholesterol. Selenium was associated with increasing HDL cholesterol only at low selenium levels. Given increasing trends in dietary selenium intake and supplementation, the causal mechanisms underlying these associations need to be fully characterized.